Company: BDRX
Filing Date: 2025-11-24
Form Type: 424B3
Source: 0001214659-25-017136
Chunk: 0

Company: Biodexa Pharmaceuticals Plc
Filing Date: 2025-11-24
Form: 424B3
Chunk 0
---
| PROSPECTUS | Filed Pursuant to Rule 424(b)(3) |
|            | Registration No. 333-272693      |

<div align='center'>BIODEXA PHARMACEUTICALS PLC

109,800,000 Ordinary Shares Representing 1,098 American Depositary Shares</div>

This prospectus relates to the resale, by the selling shareholders identified in this prospectus, of an aggregate of 109,800,000 ordinary shares, nominal value £0.000001 per share, or Ordinary Shares, of Biodexa Pharmaceuticals PLC, or the Company, represented by American Depositary Shares, or Depositary Shares, issuable upon the exercise of series D warrants, or Series D Warrants (the “Warrants”) issued in a June 2023 private placement.

The selling shareholders are identified in the table commencing on page 13. Each Depositary Share represents 100,000 Ordinary Shares. No Depositary Shares are being registered hereunder for sale by us. We will not receive any proceeds from the sale of the Depositary Shares by the selling shareholders. All net proceeds from the sale of the Ordinary Shares represented by Depositary Shares covered by this prospectus will go to the selling shareholders. However, we may receive the proceeds from any exercise of warrants in certain circumstances. See “Use of Proceeds.”

The selling shareholders may sell all or
a portion of the Ordinary Shares represented by Depositary Shares from time to time in market transactions through any market on which
our Depositary Shares are then traded, in negotiated transactions or otherwise, and at prices and on terms that will be determined by
the then prevailing market price or at negotiated prices directly or through a broker or brokers, who may act as agent or as principal
or by a combination of such methods of sale. We will bear all of the expenses incurred in connection with the registration of these shares.
The selling shareholders will pay any underwriting discounts and selling commissions and/or similar charges incurred in connection with
the sale of the shares. See “Plan of Distribution.”

Our Depositary Shares are listed on the NASDAQ Capital Market under the symbol “BDRX.” The last reported closing price of our Depositary Shares on the NASDAQ Capital Market on November 21, 2025 was $4.38.

Investing in our securities involves risks. See “Risk Factors” beginning on page 9 of this prospectus and in the documents incorporated by reference in this prospectus for a discussion of the factors you should